When was Protometrix founded?

Protometrix was founded in 2001 and raised its 1st funding round within a year of its incorporation.

Where is Protometrix located?

Protometrix is headquartered in Pittsburgh, United States.

How many employees does Protometrix have?

As of Jul 01, 2024, the latest employee count at Protometrix is 11 - 50.

Is Protometrix a funded company?

Protometrix is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on 2001.

When was the latest funding round of Protometrix?

Protometrix's latest funding was a $***** Seed round on 2001, with participation from 1 investor. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $413M in funding in 2026 to date.

Where does Protometrix rank among its competitors?

Protometrix ranks 81st amongst 86 active competitors, of which 17 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was KromaTiD, which secured $8M in Jul, 2025.

Who are the top competitors of Protometrix?

Protometrix's top competitors include PathogenDX, Inflammatix and Agendia. Among them, KromaTiD secured the most recent funding round in July, 2025.

Protometrix - 2026 Company Profile, Team, Funding & Competitors

Company Details

Life science solutions provider: reagents, instruments, and services for researchers. The company offers a wide array of products including antibodies, chemicals, lab equipment, and consumables. It serves diverse applications across life sciences, pharma, biotechnology, clinical diagnostics, and industrial sectors. The company provides comprehensive services such as lab instrument support, custom solutions, training, and partnering opportunities. It supports research by offering protein microarrays for biomarker discovery, drug target identification, and protein interaction mapping. The company provides digital solutions, eProcurement, and a supply center to streamline research workflows. The company is committed to innovation and quality, offering resources like product documentation, knowledge bases, and learning centers to empower scientists.

Website: protometrix.com
Social
Email ID: *****@thermofisher.com
Part Of

Key Metrics

Founded Year

2001

Location

Pittsburgh, United States

Stage

Acqui-Hired

Latest Funding Round

Seed, 2001, $*****

Investors

CHL Medical Partners & 1 more

Ranked

81^st among 86 active competitors

Employee Count

11 - 50 as on Jul 01, 2024

Similar Companies

PathogenDX & 121 more

View Protometrix's full profile

Protometrix has raised funding over 1 round. Its latest funding round was a Seed round on 2001 for $*****. 1 investor participated in its latest round. Protometrix has 2 institutional investors.

Here is the list of recent funding rounds of Protometrix:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
2001	7947	Seed	6439	6831	4918	4522

Access funding benchmarks and valuations. Sign up today!

View details of Protometrix's funding rounds and investors

Protometrix's employee count trend

Protometrix has 11 - 50 employees as of Jul 24. Here is Protometrix's employee count trend over the years:

Uncover Protometrix's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Protometrix include PathogenDX, Inflammatix and Agendia. Here is the list of Top 10 competitors of Protometrix, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	PathogenDX 2014, Tucson (United States), Series B	Provider of DNA-based pathogen testing kits	$11.6M	Entourage Effect Capital, GROWNEXOTICSCANNABIS ... & 10 others	64/100
2nd	Inflammatix 2016, San Francisco (United States), Series E	Provider of diagnostic solutions for systemic infections	$191M	Khosla Ventures, Think.Health & 16 others	64/100
3rd	Agendia 2003, Irvine (United States), Series F	Provider of genomic diagnostic products for the treatment of cancer	$123M	Athyrium Capital Management, Debiopharm & 9 others	59/100
4th	InDevR 2003, Boulder (United States), Acquired	Manufacturer of biotherapeutics, vaccines and diagnostic products	$16M	Adjuvant Capital, BioMerieux & 2 others	57/100
5th	KromaTiD 2007, Fort Collins (United States), Series C	Provider of molecular and genetic tests for detection of disease-causing mutations	$15.4M	Broadoak Capital Partners, First Capital Ventures ... & 4 others	56/100
6th	Geneticure 2012, Minnetonka (United States), Seed	Personalized hypertension treatment through DNA analysis for better medication selection	$1.11M	M25, Wireframe Ventures & 1 others	47/100
7th	GenomeDx Biosciences 2008, San Diego (United States), Series C	Genomic tests for urologic cancers	$69.7M	Merck Global Health Innovation Fund, Calibrium ... & 6 others	46/100
8th	Celera 1998, Los Angeles (United States), Acquired	Developer of diagnostic testing and personalized medicine	-	Tekla Capital Management, New Leaf Venture Partners ... & 1 others	46/100
9th	Affymetrix 1991, Santa Clara (United States), Acquired	Life science solutions provider: reagents, instruments, and services for scientific discovery	-	EDBI, Medicxi	44/100
10th	BioArray Solutions 2001, New York City (United States), Acquired	Beadchip for biomolecular analysis	$56.8M	NGN Capital, Axiom Venture Partners	43/100
81st	Protometrix 2001, Pittsburgh (United States), Acqui-Hired	Life science solutions provider: reagents, instruments, and services for researchers	-	CHL Medical Partners, Connecticut Innovations	21/100